Isabelle de Cremoux
CEO
Works at Seventure Partners
Investor profile | Builders Republic
About
CEO of Seventure Partners in Paris, Isabelle de Cremoux invests in Seed and Series A with check sizes ranging from €0.5 to €10 million, with a thesis focused on agrifood and life sciences. Her portfolio includes Naturex, the French leader in natural ingredients acquired by Givaudan, and COMIGEL, a player in food production. She sits on the board of both companies. Her operational background is rooted in pharma: she has notably held Business Development roles at Pfizer France and then Laboratoires Fournier. She has also served as a qualified personality on the French government's Innovation Council. A graduate of CentraleSupelec.
Profile
- Role
- CEO
- Fund
- Seventure Partners
- Nationality
- French